HAE vs RHI · P/E 35, rev $1.33B vs P/E 21, rev $5.38B
Haemonetics Corporation (HAE) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the HAE and RHI stock pages for the full models.
Not investment advice.